Recherche
-
Pharmacovigilance signals from active surveillance of mRNA platform vaccines (tozinameran and elasomeran)
(Therapies, 2023-03-11)Article de revue -
Use of psychotropic drugs in the elderly in France: Are we condemned to remain at high tide?
(Therapies, 2023-03-15)Article de revue -
Bleeding risk with concurrent use of anticoagulants and ibrutinib: A population-based nested case-control study
(British Journal of Haematology. vol. 203, n° 2, pp. 311-318, 2023-10-01)Article de revue -
Mapping Strategies to Assess and Increase the Validity of Published Disproportionality Signals: A Meta-Research Study
(Drug Safety. vol. 46, n° 9, pp. 857-866, 2023-09-01)Article de revueLibre accès -
Drug-Drug Interactions and the Risk of Emergency Hospitalizations: A Nationwide Population-Based Study
(Drug Safety. vol. 46, n° 5, pp. 449-456, 2023-05)Article de revue -
Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390
(Diabetes Care. vol. 46, n° 5, pp. e121-e122, 2023-05-01)Article de revue -
The ongoing structuring of human papillomavirus (HPV) vaccination in middle schools in Nouvelle-Aquitaine, France
(Infectious Diseases Now. vol. 53, n° 5, pp. 104717, 2023-05-04)Article de revue -
Systematic review on sex differences for drug use after stroke
(Therapies. vol. 78, pp. 213-224, 2023-03)Article de revue -
Invasive fungal infection incidence and risk factors in patients receiving ibrutinib in real-life settings: A nationwide population-based cohort study
(Mycoses, 2023-11-20)Article de revue -
Real-world effect of iloprost in patients with chronic limb-threatening ischemia (CLTI): A cohort study
(Vascular Medicine. pp. 1358863X231209263, 2023-11-07)Article de revue